The histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) induces differentiation of human breast cancer cells.

被引：0
|
作者：
Munster, PN
Rosen, N
Rifkind, R
Marks, P
Richon, V
机构：
[1] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
CLINICAL CANCER RESEARCH | 2001年 / 7卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
356
引用
收藏
页码：3725S / 3725S
页数：1
相关论文
共 50 条
  • [41] A proteomic view of the effects of histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) on prostate cancer cell line PC3
    Hong, L. T. T.
    Scharf, C.
    Hammer, E.
    Sonnemann, J.
    Beck, J. F.
    Voelker, U.
    MOLECULAR & CELLULAR PROTEOMICS, 2006, 5 (10) : S365 - S365
  • [42] Suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, protects dopaminergic neurons from neurotoxin-induced damage
    Wu, H. -M.
    Chen, S. -H.
    Hong, J. -S.
    Lu, R. -B.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S109 - S109
  • [43] Chemopreventive effect of the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) against mammary cancers induced by methylnitrosourea (MNU).
    Grubbs, C.
    Christov, K.
    Juliana, M.
    You, M.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S57 - S57
  • [44] The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells
    Hsi, LC
    Xi, XP
    Lotan, R
    Shureiqi, I
    Lippman, SM
    CANCER RESEARCH, 2004, 64 (23) : 8778 - 8781
  • [45] Histone Deacetylase (HDAC) Inhibitor, Suberoylanilide Hydroxamic Acid (SAHA), Induces Apoptosis in Prostate Cancer Cell Lines via the Akt/FOXO3a Signaling Pathway
    Shi, Xuan-Yan
    Ding, Wei
    Li, Tie-Qiu
    Zhang, Yi-Xiong
    Zhao, Shan-Chao
    MEDICAL SCIENCE MONITOR, 2017, 23 : 5793 - 5802
  • [46] Autophagy-related genes are induced by histone deacetylase inhibitor suberoylanilide hydroxamic acid via the activation of cathepsin B in human breast cancer cells
    Han, Han
    Li, Jing
    Feng, Xiuyan
    Zhou, Hui
    Guo, Shanchun
    Zhou, Weiqiang
    ONCOTARGET, 2017, 8 (32) : 53352 - 53365
  • [47] Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Suppresses Human Adenovirus Gene Expression and Replication
    Saha, Bratati
    Parks, Robin J.
    JOURNAL OF VIROLOGY, 2019, 93 (12)
  • [48] Inhibition of lymphangiogenic factor VEGF-C expression and production by the histone deacetylase inhibitor suberoylanilide hydroxamic acid in breast cancer cells
    Cheng, Hsueh-Tsen
    Hung, Wen-Chun
    ONCOLOGY REPORTS, 2013, 29 (03) : 1238 - 1244
  • [49] The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Alleviates Salinity Stress in Cassava
    Patanun, Onsaya
    Ueda, Minoru
    Itouga, Misao
    Kato, Yukari
    Utsumi, Yoshinori
    Matsui, Akihiro
    Tanaka, Maho
    Utsumi, Chikako
    Sakakibara, Hitoshi
    Yoshida, Minoru
    Narangajavana, Jarunya
    Seki, Motoaki
    FRONTIERS IN PLANT SCIENCE, 2017, 7
  • [50] Phase II trial of the histone deacetylase inhibitor vorinostat (Zolinza™, suberoylanilide hydroxamic acid, SAHA) in patients with recurrent and/or metastatic head and neck cancer
    George R. Blumenschein
    Merrill S. Kies
    Vassiliki A. Papadimitrakopoulou
    Charles Lu
    Ashok J. Kumar
    Justin L. Ricker
    Judy H. Chiao
    Cong Chen
    Stanley R. Frankel
    Investigational New Drugs, 2008, 26 : 81 - 87
12345